Last week San Francisco declared Monkeypox a public health emergency.
Now look at what happened Saturday:
So the Monkeypox names like SIGA, EBS, Bavarian Nordic, etc. are up again today.
SIGA got killed on Friday because the market focused on existing news – that SIGA’s TPOXX treatment is not approved in the US for MonkeyPox.
BUT… we all knew that. That wasn’t news. And the US is stockpiling the treatment anyway.
And if you follow the money like I do, it seems like the US will rush to approve TPOXX for monkeypox.
Plus, like with the other pandemic, I’d be willing to bet SIGA will be immune (pun intended) from any kind of liability if the treatment causes problems.
So I’m staying long.